Novo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It's Suing

Fonte: International Business Times

The lawsuit, filed Tuesday, alleges that Eli Lilly violated federal and state false advertising laws by promoting "knowingly outdated clinical trial" results that compare both companies' drugs. Scott Olson/Getty Images Novo Nordisk has escalated its battle with chief rival Eli Lilly by filing a federal lawsuit accusing the U. S.